International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s stock price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.08 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 910 shares trading hands.
International Stem Cell Stock Up 31.6 %
The firm has a fifty day simple moving average of $0.07 and a two-hundred day simple moving average of $0.08.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Further Reading
- Five stocks we like better than International Stem Cell
- What is a Death Cross in Stocks?
- Super Micro Computer Soars 28%: Is It Really Out of the Woods?
- 3 REITs to Buy and Hold for the Long Term
- Traders Are Flocking Back to Oil: What’s Fueling the Optimism
- With Risk Tolerance, One Size Does Not Fit All
- 3 Hot Stock Trends to Ride Into 2025
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
